Poseida Therapeutics Company
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Investors
Technology:
CAR-T therapy
Industry:
Gene Therapy, Public
Headquarters:
San Diego, California, United States
Founded Date:
2014-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
15
Total Funding:
410450002
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-08-04
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership